These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29325364)

  • 1. [The efficacy and safety of coil embolization of septal branch in the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu H; Wu Q; Tan HW; Pang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1044-1048. PubMed ID: 29325364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 3. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effects of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy].
    Li PJ; Sun JJ; Chen ML; Yu XP; Zhao H; Gao YC; Zhang XL; Jiang TY; He JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Apr; 50(4):369-374. PubMed ID: 35399033
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up.
    Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A
    Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic changes in percutaneous transluminal septal coil embolization for hypertrophic obstructive cardiomyopathy.
    Ramcharitar S; Meliga E; Kirschbaum SW; ten Cate FJ; van Geuns RJ; Serruys PW
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):806-10. PubMed ID: 18838967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-drug treatment for hypertrophic obstructive cardiomyopathy in children].
    Zhang X; Li YF; Xie B; Chen JY; Qian MY
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):381-5. PubMed ID: 21624293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
    Gross CM; Schulz-Menger J; Krämer J; Siegel I; Pilz B; Waigand J; Friedrich MG; Uhlich F; Dietz R
    J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.
    Faber L; Meissner A; Ziemssen P; Seggewiss H
    Heart; 2000 Mar; 83(3):326-31. PubMed ID: 10677415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: Single center experience.
    Asil S; Kaya B; Canpolat U; Yorgun H; Şahiner L; Çöteli C; Arat A; Aytemir K
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):557-565. PubMed ID: 29205803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Guerrero I; Dhoble A; Fasulo M; Denktas AE; Sami S; Choi S; Balan P; Arain SA; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):971-977. PubMed ID: 27511120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and management of complete heart block after transaortic extended septal myectomy in patients with hypertrophic obstructive cardiomyopathy].
    Luo MY; Wang SY; Sun HT; Yin ZH; Sun X; Song YH; Hu SS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):598-601. PubMed ID: 24284190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcome and related predictors of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy].
    Liu R; Qiao SB; Hu FH; Yang WX; Yuan JS; Cui JG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):771-776. PubMed ID: 27667275
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of cardiac magnetic resonance on predicting outcome in patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation].
    Du H; Lu M; Yin G; Yin X; Jiang Y; Wang J; Chen X; Song L; Huang J; Zhang Y; Zhao S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug; 42(8):665-9. PubMed ID: 25388340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
    Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Kazmierczak J; Kornacewicz-Jach Z; Kisly M; Gil R; Wojtarowicz A
    Heart; 1998 Sep; 80(3):257-62. PubMed ID: 9875085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of alcohol septal ablation in mildly symptomatic or severely symptomatic patients with hypertrophic obstructive cardiomyopathy].
    Sun JJ; Li PJ; Yu XP; Zhao H; Zhang XL; Tu CC; Zhang MD; Jiang TY; Song XT; He JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):513-520. PubMed ID: 37198123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.